Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Ukończone leczenie wewnątrzmaciczne (do pęcherza) raka pęcherza w ciągu ostatniego roku (dla grupy 1)
- •Doświadczenie w podawaniu zastrzyków BCG przez co najmniej 2 lata (dla pracowników medycznych w grupie 1)
- •Rozpoznany rak pęcherza i przepisane leczenie BCG (dla grupy 2)
✗ Disqualifies
- •Brak możliwości wyrażenia świadomej zgody na udział w badaniu
- •Brak możliwości wprowadzenia cewnika do pęcherza
- •Wcześniejsza niepożądana reakcja na leczenie BCG
- •Brak dostępu do telefonu komórkowego
- •Brak możliwości pisania w języku angielskim
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 5, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Abramson Cancer Center
Philadelphia, United States
Trial contact
Daniel Lee, PI, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/6/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.